Eisai Innovation
2 rounds tracked since 18 February 2026.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $72.4M
Sectors
Countries
Rounds
- Excalipoint TherapeuticsClinical-stage biotechnology company developing novel therapeutics, details limited in the roundup. $68.7MSeed · 18 Mar
- Sift BiosciencesAI-driven peptide immunotherapies that activate memory T cells against cancer $3.7MPre-Seed · 18 Feb
No round matches these filters.